Harbor Capital Advisors, Inc. Synlogic, Inc. Transaction History

Harbor Capital Advisors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 11, 2023	BUY	$0.42 - $0.68 $11,163 - $18,073	26,579 Added 10.07%	290,605 $124,000
Q1 2023 Apr 26, 2023	SELL	$0.56 - $1.07 $26,620 - $50,864	-47,537 Reduced 15.26%	264,026 $166,000
Q4 2022 Jan 20, 2023	SELL	$0.58 - $17.99 $3,912 - $121,360	-6,746 Reduced 2.12%	311,563 $0
Q3 2022 Oct 28, 2022	SELL	$0.91 - $14.63 $32,264 - $518,721	-35,456 Reduced 10.02%	318,309 $302,000
Q2 2022 Jul 26, 2022	SELL	$0.89 - $2.47 $1,097 - $3,045	-1,233 Reduced 0.35%	353,765 $407,000
Q1 2022 Apr 28, 2022	SELL	$1.63 - $2.55 $134,559 - $210,507	-82,552 Reduced 18.87%	354,998 $852,000
Q4 2021 Feb 04, 2022	BUY	$2.27 - $3.0 $993,238 - $1.31 Million	437,550 New	437,550 $1.06 Million

25.5K

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $105M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

Get notified when there are updates to the investment portfolio of Harbor Capital Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbor Capital Advisors, Inc. with notifications on news.